DiCOM SANAQ® – a move forward into direct compression

Pharmatrans Sanaq introduces DICOM SANAQ® a range of co-processed excipients with high functionality as an innovative platform for higher quality direct compression (DC) formulations. The webinar will be held November 10, 2020 – 02:00 PM European Time.

Why should attend the webinar and message to bring back at home

–           Co Processed excipients in Direct Compression use

–           DiCOM SANAQ a new option in solid dosage formulation management

–           Practical examples of utility and effectivness

–           How DiCOM SANAQ could be worth for your process

Introduction of the Webinar:

With its research & development skills and traditions, Pharmatrans Sanaq is committed to finding innovative technological solutions providing excipients contributing successfully to smart and efficient pharmaceutical formulations.

The new DICOM SANAQ line expands the boundaries of DC in oral dosage formulations, where previous state of the art recognized that some current excipients and API were sub-optimal for used in CM for several reasons, including issues related to use of multiple feeders.

DICOM SANAQ offers ready-made blends suitable for producing ideal formulations in specific applications. These excipient mixtures exhibit excellent and superior compressibility parameters compared with single and pure excipients.

The use of DICOM SANAQ high functionality co-processed excipient enhances product performance reducing formulation variability and improving the process cost effectivness

DICOM SANAQ is a new a choice for the formulator looking to simplify and accelerates the product manufacturing process in a safe and valid regulatory environment.